In the ZEUS study, we will investigate if the study medicine called ‘Ziltivekimab’ can reduce the risk of stroke, heart attack and death, from cardiovascular causes in people with inflammation in their blood vessels.
"*" indicates required fields
The eClinicalWorks web-based Patient Portal lets patients and doctors communicate easily, safely and securely over the Internet. Patients are given secure passwords that allow them to log in to see their own private set of documents including statements and communications from their physicians.
To proceed read the Terms and Conditions and click the link below
I have read and agreed to the Terms & Conditions for usage of the Patient Portal serviceThe eClinicalWorks web-based Patient Portal lets patients and doctors communicate easily, safely and securely over the Internet. Patients are given secure passwords that allow them to log in to see their own private set of documents including statements and communications from their physicians.
To proceed read the Terms and Conditions and click the link below
I have read and agreed to the Terms & Conditions for usage of the Patient Portal service